s6y
Company name or ticker
Search
NRX Pharmaceuticals, Inc.
3
B Group, Inc.: Initial statement of beneficial ownership of securities
Filed
Thursday, August 21, 2025
Period
Aug 18, 2025
Accession number
0001213900-25-079145
Documents
ownership.xml
3
On sec.gov
Filing index
All files
Complete submission text
SGML header